Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure

Cellular Immunology

Volumn 279, Issue 2, 2012, Pages 180-186

  Brelaz de Castro, Maria Carolina Accioly ^a   de Almeida, Amanda Ferreira ^a   de Oliveira, Andresa Pereira ^a   de Assis Souza, Marina ^a   da Rocha, Lucas Ferreira ^a   Pereira, Valéria Rêgo Alves ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

American cutaneous leishmaniasis; Antigen; Cytokines; Flow cytometry; Immune response; T lymphocyte

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LEISHMANIA BRAZILIENSIS ANTIGEN; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMERICAN CUTANEOUS LEISHMANIASIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; EX VIVO STUDY; HEALING; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; SKIN LEISHMANIASIS; T LYMPHOCYTE;

ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

LEISHMANIA BRAZILIENSIS;

EID: 84871003450     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.11.006     Document Type: Article

References (31)

1. Reithinger R., Dujardin J.C., Louzir H., Pirmez C., Alexander B., Brooker S. Cutaneous Leishmaniasis. Lancet Infect. Dis. 2007, 7:581-596.
2. WHO. World Health Organization (accessed January 2012). http://www.who.int/leishmaniasis/burden/en/.
3. Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin. Exp. Dermatol. 2010, 35:699-705.
4. Leopoldo P.T.G., Machado P.R.L., Almeida R.P., Schriefer A., Giudice A., Ribeiro de Jesus A.R., Ho J., Guimarães L.H., Bacellar O., Carvalho E.M. Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production. BMC Infect. Dis. 2006, 6:75.
5. Brelaz M.C.A., Oliveira A.P., Almeida A.F., Souza M.A., Medeiros A.C.R., Brito M.E.F., Pereira V.R.A. Leishmania (Viannia) braziliensisantigenic fractions: the immune response characterization of patients at the initial phase of disease. Parasite Immunol. 2012, 34(4):236-239.
6. Castellano L.R., Filho D.C., Argiro L., Dessein H., Prata A., Rodrigues V. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Hum. Immunol. 2009, 70(6):383-390.
7. Bittar R.C., Nogueira R.S., Vieira-Gonçalves R., Pinho-Ribeiro V., Mattos M.S., Oliveira-Neto M.P., Coutinho S.G. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis. Mem. Inst. Oswaldo Cruz 2007, 102(5):625-630.
8. L.R. Antonelli, W.O. Dutra, R.P. Almeida, O. Barcellar, E.M. Carvalho, K.J. Gollob, Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis, Immunol. Lett. 101 (2005) 226-230.
9. A.M. Da-Cruz, A.L. Bertho, M.P. Oliveira-Neto, S.G. Coutinho, Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions, Br. J. Dermatol. 153 (3) (2005) 537-543.
10. A. Gomes-Silva, R.C. Bittar, R.S. Nogueira, V.S. Amato, M.S. Mattos, M.P. Oliveira-Neto, S.G. Coutinho, A.M. da-Cruz, Can interferon-γ and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clin. Exp. Immunol. 149 (2007) 440-444.
11. Baratta-Masini A., Teixeira-Carvalho A., Malaquias L.C.C., Mayrink W., Martins-Filho A.O., Corrêa-Oliveira R. Mixed cytokine profile during active cutaneous leishmaniasis and in natural resistance. Front. Biosci. 2007, 12:839-849.
12. + T cells in patients with American cutaneous leishmaniasis. Clin. Exp. Immunol. 2012, 167(3):505-513.
13. M.E.F. Brito, M.G. Mendonça, Y.M. Gomes, M.L. Jardim, F.G.C. Abath, Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis, Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 203-206.
14. S.G. Coutinho, A.M. Da-Cruz, A.L. Bertho, M.A. Santiago, P. De-Luca, Immunologic patterns associated with cure in human American cutaneous leishmaniasis, Braz. J. Med. Biol. Res. 31 (1998) 139-142.
15. Da-Cruz A.M., Conceição-Silva F., Bertho A.L., Coutinho S.G. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect. Immun. 1994, 62(6):2614-2618.
16. R.L.A. Bottrel, W.O. Dutra, F.A. Martins, B. Gontijo, E. Carvalho, M. Barral-Netto, R.P. Almeida, W. Mayrink, R. Locksley, K.J. Gollob, Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble leishmania antigen in human cutaneous leishmaniasis, Infect. Immun. 69 (5) (2001) 3232-3239.
17. Belkaid Y. Regulatory T cells and infections: a dangerous necessity. Nat. Rev. Immunol. 2007, 7:875-888.
18. Coutinho S.G., Oliveira M.P., Da-Cruz A.M., De Luca P.M., Mendonça S.C., Bertho A.L., Soong L., McMahon-Pratt D. T-cell responsiveness of American cutaneous leishmaniasis patients to purified leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Exp. Parasitol. 1996, 84:144-155.
19. Da-Cruz A.M., Bittar R., Mattos M., Oliveira-Neto M.P., Nogueira R., Pinho-Ribeiro V., Azeredo-Coutinho R.B., Coutinho S.G. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin. Diagn. Lab. Immunol. 2002, 9(2):251-256.
20. Toledo V.P., Mayrink W., Gollob K.J., Oliveira M.A., Costa C.A., Genaro O., Pinto J.A., Afonso L.C. Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Mem. Inst. Oswaldo Cruz 2001, 96(1):89-98.
21. P. Autissier, C. Soulas, T.H. Burdo, K.C. Williams, Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans, Cytometry Part A 77 (5) (2010) 410-419.
22. A.M. Faria, S.M. de Moraes, L.H. de Freitas, E. Speziali, T.F. Soares, S.P. Figueiredo-Neves, D.M. Vitelli-Avelar, M.A. Martins, K.V. Barbosa, E.B. Soares, R. Sathler-Avelar, V. Peruhype-Magalhães, G.M. Cardoso, F. Comin, R. Teixeira, S.M. Elói-Santos, D.M. Queiroz, R. Corrêa-Oliveira, M.E. Bauer, A. Teixeira-Carvalho, O.A. Martins-Filho, Variation rhythms of lymphocyte subsets during healthy aging, Neuroimmunomodulation 15 (4-6) (2008) 365-379.
23. Botelho A.C., Mayrink W., Oliveira R.C. Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine. Acta Trop. 2009, 12(2):143-148.
24. Gomes-Silva A., Bittar R.C., Nogueira R.S., Amato V.S., Mattos M.S., Oliveira-Neto M.P., Coutinho S.G., Da-Cruz A.M. Can interferon-γ and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?. Clin. Exp. Immunol. 2007, 149:440-444.
25. L.C. Reis, M.E.F. Brito, M.A. Souza, A.C. Medeiros, C.J. Silva, C.F. Luna, V.R.A. Pereira, Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment, J. Clin. Lab. Anal. 23 (2009) 63-69.
26. Telino E., De Luca P.M., Matos D.C., Azeredo-Coutinho R.B., Meirelles M.N., Conceição-Silva F., Schubach A., Mendonça S.C. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin. Exp. Immunol. 2005, 143:338-344.
27. Salhi A., Rodrigues V., Santoro F., Dessein H., Romano A., Castellano L.R., Sertorio M., Rafati S., Chevillard C., Prata A., Alcaïs A., Argiro L., Dessein A. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J. Immunol. 2008, 180(9):6139-6148.
28. Schriefer A., Wilson M.E., Carvalho E.M. Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis. Curr. Opin. Infect. Dis. 2008, 21(5):483-488.
29. Ajdary S., Alimohammadian M.H., Eslami M.B., Kemp K., Kharazmi A. Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect. Immun. 2000, 68(4):1760-1764.
30. Bourreau E., Ronet C., Darcissac E., Lise M.C., Sainte Marie D., Clity E., Tacchini-Cottier F., Couppie P., Launois P. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect. Immun. 2009, 77(4):1465-1474.
31. M.A. Souza, M.C.A.B. Castro, A.P. Oliveira, A.F. Almeida, L.C. Reis, C.J. Silva, M.E.F. Brito, V.R.A. Pereira, American tegumentary leishmaniasis: cytokines and nitric oxide in active disease and after clinical cure, with or without chemotherapy, Scand. J. Immunol. 76 (2) (2012) 175-180.